Vertex Pharmaceuticals, a biotech company, recently released its earnings report. It was a bit of a mixed bag! While they made more money than expected, their stock price went down a little.
- Vertex made a lot of money from its cystic fibrosis medicines.
- They have some new medicines coming out soon.
- Some analysts are very optimistic, while others are more cautious.
| Fact | Number |
|---|---|
| Earnings per share | $3.98 |
| Total sales | $2.91 billion |
| Sales prediction for 2025 | $11.75 - $12 billion |
| Highest price target | $533 |
| Lowest price target | $407 |
